Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1998Journal of Antimicrobial ChemotherapyOpen Access

In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B

View Full Paper
Ask AI
Bookmark
Share

Authors

KOKevin OakleyUniformed Services University of the Health Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kevin Oakley (1998) studied this question.

synapsesocial.com/papers/6a98c9833c2ace4a277486ebhttps://doi.org/10.1093/jac/42.1.91
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens1997 · 190 citations
  2. 2In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species1996 · 124 citations
  3. 3Treatment of fungal infection in AIDS1996 · 44 citations
  4. 4Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection1997 · 236 citations
  5. 5National Committee for Clinical Laboratory Standards1980 · 14,792 citations